ArticlePloS one2019

Mexican BRCA1 founder mutation: Shortening the gap in genetic assessment for hereditary breast and ovarian cancer patients.

Veronica Fragoso-Ontiveros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.